ACIMD 2027
ABSTRACT SUBMISSION GUIDELINES
- Abstracts must be submitted and presented in English.
- The presenting author must be registered for the conference.
- Abstracts must report original research related to inherited metabolic disorders and must not have been previously published.
- The abstract must not exceed 250 words, excluding the title, author details, category/subcategory and keywords.
- Authors must select the primary category and corresponding subcategory that best represent the central focus of their abstract. Abstracts addressing multiple aspects of an inherited metabolic disorder should be classified according to their principal research question.
- References, tables and figures are not required.
- The presenting author must be identified at the time of submission and is responsible for ensuring that all co-authors have approved the abstract.
- The Scientific Committee reserves the right to reclassify abstracts into an appropriate category.
ABSTRACT PRESENTATION FORMATS
The submitted abstracts could be selected for one of the following categories:
- 01 Oral Platform Presentation
- 02 Printed / Physical Poster Presentation
- 03 E-Poster or Digital Poster Presentation
The Scientific Committee will determine whether an abstract is selected for oral or poster presentation based on scientific merit, relevance and available presentation slots. The committee's decision will be final.
ABSTRACT CATEGORIES
Select a category to view its corresponding subcategories. Authors should choose the category that best represents the primary focus of their research.
ABSTRACT CATEGORY DEFINITIONS
Spotlight Sessions
Uncommon Presentations of Common Metabolic Disorders
A session highlighting unusual clinical presentations, atypical phenotypes, unexpected complications or diagnostic challenges associated with common inherited metabolic disorders. The focus will be on clinical insights that challenge conventional understanding and offer important lessons for diagnosis and management.
Rare Discoveries, Real Impact
A session showcasing groundbreaking discoveries in inherited metabolic disorders, including novel disease genes, previously unrecognized disorders, innovative therapeutic approaches, gene therapy and gene-editing strategies. Emphasis will be placed on scientific novelty, translational potential and the impact of these advances on patient care.
Rising Stars in Metabolic Medicine
A dedicated platform for young researchers and clinicians to showcase their original research in inherited metabolic disorders. Submissions may include clinical research, novel disease discoveries, advances in diagnostics, disease mechanisms and therapeutic innovations. The session aims to encourage emerging talent, foster scientific exchange and recognize promising contributions to metabolic medicine.
Share Your Research With The Scientific Community
Submit your original research and be a part of ACIMD 2027.
Submit Your Abstract →